ChromoLogic
Company profile
Primary focus
Applied research and commercialization of technologies for medical, aerospace, and security markets, with a focus on point-of-care biomedical devices, diagnostics, drug-delivery platforms, optical instrumentation, neuromorphic software, and supply-chain traceability.
Why it’s included
The company develops and manufactures 'Quick-MAG,' a low-cost rugged magneto-optical sensing system for highly-sensitive malaria screening, explicitly addressing field-suitable rapid diagnostics for malaria in resource-limited settings and low-parasitemia contexts.
Relevant capabilities
- Magneto-optical detection for parasitemia and hemozoin measurement
- Nucleic acid diagnostics and point-of-care assay development
- Microbial genome enrichment and low-biomass sequencing workflows
- In‑line, non‑invasive optical cell monitoring (OCT-based)
- Optical coherence tomography for structural and biomechanical measurements
Commercial sectorUltrasensitive and Reader-Assisted Diagnostic Platforms
Technology classesCRISPR-based nucleic acid detection
Relevant commercial products
- Quick-MAG
- QuickMag
- CAPTIN-D
- Point-of-care nucleic acid diagnostic workflows
- PANACIA™
Relevant patents
4 families, 5 publications- Tag free bio sensing micro strip US-8142723-B2
- Integrated membrane for preservation of biomolecules US-9933343-B2
- Integrated membrane device US-10717022-B2
- Non-invasive ocular monitoring US-8666465-B2